SOAT1 and rheumatoid arthritis: This finding suggests that microneedle-mediated delivery of Tofacitinib and NAC effectively suppresses hyperactive JAK–STAT signaling, thereby modulating adaptive immune responses, reducing inflammatory burden, and mitigating tissue damage in RA.